Rheumnow Podcast
Dr. Jack Cush reviews the latest news, journal reports, and regulatory decisions from the past week in rheumatology, providing concise updates for healthcare professionals.
Episodes
Rheum Scholarship (8.21.2026)
Dr. Cush reviews the news and journal articles from this past week on RheumNow.com; talking about lumbar belts, scholarships and misdiagnosis.
Doubting RS3PE (8.14.2026)
Dr. Jack Cush reviews the news and journal articles this week where RheumNow featured info on cancer, deadly viruses, AI rules, poetry and good moons rising.
Mentshlichkeit (8.7.2026)
Dr. Jack Cush reviews the news and recent journal reports on RheumNow.com
A JAKi After TNFi Failure in RA: SELECT-SWITCH at Week 12
Dr. Christina Charles-Schoeman and Dr. Manish Jain are back to discuss treatment considerations after TNFi failure in RA. Join them as they review the latest data from SELECT-SWITCH, including post hoc results in primary and secondary nonresponders presented at EULAR 2026. Learn how those findings impact their clinical decision-making. Sponsored by AbbVie Medical Affairs + Health Impact
TU: Systemic Burden of Gout Part 2 (24 plus)
Dr. Jack Cush Obesity & Gout
Dr. Tony Merriman Genome-Wide Association Studies in Gout
Dr. Lisa Stamp Gout Management in Patients with Chronic Kidney Disease
Dr. Mark Fisher Gout & Mortality
Methotrexate Safety Tips (7.31.2026)
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Gout Lessons from the Clinic Part 3
Dr. Sheila Reyes: QD Clinic: The Highs and Lows of a Woman with Gout
Dr. Jack Cush QD319 A Watched Tophus Never Resolves
Dr. Eric Dein QD316: Addressing Severe Gout Flares
Dr. Janet Pope QD Clinic: RA Mimics — Two Cases That Turned Out to Be Gout
DERM on RheumNow (July 2026)
The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, CTD skin disorders. dermatology drugs, biologics, andJAK inhibitors - their use, efficacy and side effects.
Features Dr. Jack Cush, Editor at RheumNow.com.
Show Notes:
- 20 yr. Tx trends in 6583 #SSc pts. 2005 to 2025 endothelin receptor antagonists
New, Advanced Therapies in Gout
New, Advanced Therapies in Gout explores the rapidly evolving therapeutic landscape beyond conventional urate-lowering therapy. Join our expert panel as they discuss emerging approaches—including cytokine inhibition, uricase therapies, NLRP3 and URAT-1 inhibitors, and the potential role of GLP-1 receptor agonists and SGLT2 inhibitors—while addressing which patients are most likely to benefit, how
Systemic Burden of Gout Part 1
Dr. Robert Terkeltaub 3 New Things it Pays to Know About Gout Pathobiology
Dr. Nicola Dalbeth Outcomes of Tophaceous Gout
Dr. Ted Mikuls Subclinical Inflammation in Intercritical Gout
Dr. Michael Pillinger Gout and Cardiovascular Disease: What's the Risk? What's the Connection?
Better Gout Management
Dr. John Fitzgerald Gout & Metabolic syndrome
Dr. Karon Jatuworpruk Predicting and managing gout flares in hospitalised patients
Dr. Richard Conway Bespoke Telehealth in Gout: A Missed Opportunity
Gout Advice & Tips
Dr. Robert Terkeltaub Four things you need to know about allopurinol hypersensitivity syndrome
Dr. Angelo Gaffo Challenges in Gout Diagnosis
Dr. Janet Pope Tips for safe use of allopurinol in patients with gout
Gout Lessons from the Clinic Part 2
Dr Janet Pope: QD Clinic: Can RA and Gout Manifest Simultaneously?
Dr. Mrinalini Dey QD312: Gout, Sepsis… or Both?
Daric Mueller, PA-C QD315: Pegloticase Immunomodulation: What’s on the Menu?
Dr. Richard Conway: QD313: Don't Presume on IL-1 in Gout
Chikungunya Club Meeting (7.24.2026)
Dr. Jack Cush reviews the news, journal reports from the past week on RheumNow.com
Upgrading & Maximizing the Classics (Colchicine, Allopurinol, etc.)
Upgrading & Maximizing the Classics (Colchicine, Allopurinol, etc.) examines how to optimize the use of time-tested gout therapies in today's increasingly complex patients. Through practical case discussions, our expert faculty will address colchicine safety and dosing in chronic kidney disease, selecting first-line therapy for acute flares, initiating and titrating urate-lowering therapy, imp
Seronegative RA Disease Activity (7.17.2026)
Dr. Jack Cush reviews the news, journal articles and Gout features from this past week on RheumNow.com
What Lies Beneath - Uric Acid Deposition & Imaging
This webinar explores the evolving role of imaging in the diagnosis and management of gout. Our expert panel will discuss when and how to use ultrasound, dual-energy CT (DECT), crystal identification, and conventional radiography, while addressing practical questions such as the role of imaging in diagnostic uncertainty, serial disease monitoring, and whether ultrasound is changing the need for sy
Gout QD clinics - lessons from the Clinic QD307-QD311
QD307: Senior Year Gout https://youtu.be/_TGgcdQsfic
QD308: Allopurinol for All Gout? Not Quite https://youtu.be/JAwUb-hqeFs
QD309: Cellulitis Paradoxes https://youtu.be/j3feySk5wQo
QD310: Gout: Is it the Journey or the Destination? https://youtu.be/1J-ZrbaGsD8
QD311: When There's Doubt in Gout https://youtu.be/DpAevfq7Oo0
Gout Cavalcade (7.10.2026)
Dr. Jack Cush reviews the news, journal articles and regulatory decisions from the past week. July is Gout: More than Flares month. Visit https://rheumnow.com/campaign/gout-campaign-july-2026 for all of our coverage throughout July.
Gout Journal Club
Gout Journal Club will examine two influential publications: 1. "Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients with Gout" (Cipolletta et al., JAMA Internal Medicine, 2026) and 2. "Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease"(Wang et al., JAMA Internal Medicine, 2025). Together, these studies provi
Podcast Replay: Is it Time to Transition MOAs in RA?
In August, Dr. Christina Charles-Schoeman and Dr. Manish Jain will return with a new episode exploring the latest clinical data on RA treatment after TNFi failure. Before that episode drops, revisit their 2025 conversation on disease control, real-world data, and guidelines that inform clinical decision-making after TNFi failure. Sponsored by AbbVie Medical Affairs + Health Impact.
ICYMI: Great Lectures; Great Presentations
Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.
Generic Tofacitinib (6.26.2026)
Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Updates on tofacitinib, CAR-T therapy and AI.
DERM on RheumNow (June 2026)
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.
Features Dr. Jack Cush, Editor at RheumNow.com.
Show Notes:
- Breckenridge Pharmaceutical received FDA approval for their generic version of tofacitini
Do You Zoster Vaccinate? (6.19.2026)
Dr. Jack Cush reviews the news, journal reports and best ways to review EULAR 2026.
RheumNow EULAR 2026 Rheumatology Round Up
Drs. Jack Cush & Arthur Kavanaugh, two of rheumatology’s most trusted voices, provide a breakdown of the latest breakthroughs and hottest topics in rheumatology from the EULAR 2026 meeting in London.
EULAR 2026 RA Topic Panel
Join Drs. Bella Mehta, Jack Cush, Janet Pope, and Jon Kay for a focused conversation on the latest in rheumatoid arthritis care from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what’s shaping RA practice right now.
CAR-T Topic Panel EULAR 2026
Join Drs. Jack Cush, Alfred Kim, Janet Pope, and Yuz Yusof for a focused conversation on the latest in CAR-T from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what's shaping CAR-T practice right now.
EULAR 2026 PsA Update What's Changing in Psoriatic Arthritis Care?
Join Drs. Jack Cush, Peter Nash, Antoni Chan, and Nelly Ziade for an expert discussion on the most important psoriatic arthritis developments emerging from EULAR 2026.
This focused conversation explores new clinical data, evolving treatment strategies, and practical approaches to managing PsA in everyday practice. From advances in biologic and targeted therapies to ongoing challenges in diagnosis,
RA Topic Podcast compilation
2026 EULAR Preview
Beyond BMI: Altered Body Composition in Rheumatoid Arthritis
CAR-T For Rheumatoid Arthritis
This Is a Woman’s World: Women's Health in Rheumatic Disease
Low dose Blinatumomab: Many Relapse with an Unexpected Surprise
Doctor's Orders or Patient's Choice: BACH study findings
Another Way to Leverage NK Cells to Kill B Cells, This Time Without CARs
Digital Patient Education in RA
Ma
PsA Topic Podcast compilation
2026 EULAR Preview
Imaging in Subclinical Psoriatic Arthritis
Dietary Interventions in PsA
This Is a Woman’s World: Women's Health in Rheumatic Disease
Impact of Synovial Biopsy-Driven Therapeutic Stratification in PsA
Can We Stop PsA Before it Starts?
BE BOLD: Going Where No PsA Trial Has Gone Before
BMI Outranks Treatment in PsA Outcomes?
Debate: Combination Therapies for Inflammatory Arthritis?
CAR T Topic compilation
2026 EULAR Preview
CAR-T For Rheumatoid Arthritis
What Happens when CAR-T Fails Managing Disease Recurrence
Management of Relapses After CAR-T Therapy in SLE, SSc and IIM
How Many CAR-Ts Do We Need to Test Drive?
EULAR 2026 Daily Podcast Day 4c
Guselkumab Delivers Across the PsA Disease Spectrum: APEX Trial
RA BRIDGE and RA BRANCH trials: Baricitinib and VTE Risk
Improving Referrals for Inflammatory Arthritis"
Combination Therapy: Off the Shelf Allogenic NK and Rituximab in Rheumatic Disease
EULAR 2026 Daily Podcast Day 4b
Are we failing in the treatment of RA-ILD?
Using AI to Predict Progression to RA
Treat to Target Works in Elderly Onset RA
EULAR 2026 Daily Podcast Day 4a
MACE and Safety Profile of bDMARDs/JAKis in axSpA and PsA
How Many CAR-Ts Do We Need to Test Drive?
Making Methotrexate More Effective
Day 4 Recap EULAR 2026
Join Drs. Jack Cush, Mrinalini Dey, Antoni Chan, and Yuz Yusof for a lively discussion of the top presentations, breakthrough science, and clinical pearls from Day 4 of the EULAR 2026 Congress. Abstracts discussed included:
LB001
LB002
LB003
LB005
LB007
LB009
RA Plenary
POS1350
EULAR 2026 Daily Podcast Day 3a
Debate: Combination Therapies for Inflammatory Arthritis?
Combination Biologics in PsA: MRI Findings from AFFINITY
Combination Therapy in SpA
Digital Patient Education in RA
The Case for Dual Pathway Blockade in Refractory PsA
The AFFINITY Study: Combination Treatment in PsA
PsA Potpourri: Probiotics & Head-to-Head Data
Transition from Psoriasis to Psoriatic Arthritis
Day 3 Recap EULAR 2026
Join Drs. Jack Cush, Jiha Lee, Nelly Ziade, and Sheila Reyes for a lively discussion of the top presentations, breakthrough science, and clinical pearls from Days 3 of the EULAR 2026 Congress. Abstracts discussed included:
OP0348
POS0290
OP0342
POS1068
POS0201
POS0288
EULAR 2026 Daily Podcast Day 2c
BE BOLD: Going Where No PsA Trial Has Gone Before
BMI Outranks Treatment in PsA Outcomes?
What Happens when CAR-T Fails Managing Disease Recurrence
Management of Relapses After CAR-T Therapy in SLE, SSc and IIM
Doctor's Orders or Patient's Choice: BACH study findings
Another Way to Leverage NK Cells to Kill B Cells, This Time Without CARs
EULAR 2026 Daily Podcast Day 2b
Low dose Blinatumomab: Many Relapse with an Unexpected Surprise
Can We Stop PsA Before it Starts?
Impact of Synovial Biopsy-Driven Therapeutic Stratification in PsA
Daily Recap Day 1 + 2 EULAR 2026
Join Dr. Jack Cush and RheumNow.com faculty for a lively discussion of the top presentations, breakthrough science, and clinical pearls from Days 1 & 2 of the EULAR 2026 Congress. Abstracts discussed included:
OP0177
OP0244
OP001
OP008
OP0205
OP018
OP0204
POS0788
EULAR 2026 Daily Podcast Day 2a
Imaging in Subclinical Psoriatic Arthritis
CAR-T For Rheumatoid Arthritis
This Is a Woman’s World: Women's Health in Rheumatic Disease
Dietary Interventions in PsA
EULAR 2026 Daily Podcast Day 1a
2026 EULAR Preview - Dr. Jack Cush
‘Strong’ Treatment Predictions in Inflammatory Myositis - Dr. Janet Pope
Beyond BMI: Altered Body Composition in Rheumatoid Arthritis - Dr Mrinalini Dey
Why PROMS Matter in the Care of People with Lupus - Dr. Mrinalini Dey
Count Your Telangiectasias (5.29.2026)
Dr. Jack Cush reviews the news, journal articles and missed quiz question.
Quiz Talk (5.22.2026)
Dr. Jack Cush talks of birthdays, Quizes and journal articles this week on the podcast.
Infectious Rheumatology (5.15.2026)
Dr. Jack Cush discusses his favorite journal articles from the past week on RheumNow.com.
Influential Rheumatoid Factors(5/8/2026)
Dr Jack Cush reviews the news and journal reports from last weekon rheumnow.com
Great Lectures; Great Presentations
Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.
DERM on RheumNow (April 2026)
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.
Features Dr. Jack Cush, Editor at RheumNow.com.
Show Notes:
Chinese target emulation trial of MDA-5+, dermatomyositis w/ ILD. 106 Rx w/ UPA & 328
Follow the Money (4.23.2026)
Dr. Jack Cush follows the money and all the news that fits the Rheumatology Gab for this past week.
Prescribing Lessons (4.17.2026)
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.
Top Four and More (4.10.2026)
Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week - including his top four favorite subjects.
Whats New PsA? (4.3.2026)
Dr. Jack Cush reviews the news and major articles from this week, including FDA safety warnings, reports from AAD, PsA trials.
Addressing PsA GRAPPA Domains With a JAKi
Dr. Schwartzman and Dr. Ruderman discuss the importance of a domain-based approach in PsA management and consider the potential role of a JAK inhibitor. Sponsored by AbbVie Medical Affairs + Health Impact.
https://buff.ly/9gUnxB7
Moral Distress (3.27.2026)
Dr. Jack Cush reviews the journal reports and news from RheumNow.com. This week we discuss moral distress, FM in PsA, Lyme Vax is back & hidden but tangible benefits of the MDHAQ.
DERM on RheumNow Podcast (March 2026)
This month: Multiple FDA regulatory decisions germane to dermatology, psoriasis and lupus; and Eosinophilic Fasciitis (EF) reminder and should you worry about fibromyalgia?
Show Notes:
1. FDA Approves Icotrokinra for Plaque Psoriasis The FDA approved an oral IL-23 inhibitor, icotrokinra (Icotyde), for use in moderate-to-severe plaque psoriasis in adults and children 12 years of age and older who a
Pitfalls in Rheumatology (3.20.2026)
Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past week on RheumNow.com
STEP Talks from RNL26 Part #2
STEP: Obesity and Inflammation: Weight management in Rheumatology. Dr. Uzma Haque
STEP: Mitigating Risk for Rheumatic Disease Patients Undergoing Orthopedic Surgery. Dr. Susan Goodman
STEP Talks from RNL26 Part #1
STEP: Disease Modification in OA - Dr. Tuhina Neogi
STEP: History of Gout - Dr. Robert Terkeltaub
Rheumatoid Arthritis Faculty Panel Q&A
Rheumatoid Arthritis Faculty Panel Q&A
ILD in RA - Recent Advances. Dr. Jeffrey Sparks
ILD in RA - Recent Advances. Dr. Jeffrey Sparks
The Mucosal Hypothesis of Rheumatoid Arthritis. Dr. Kristin Demoruelle
The Mucosal Hypothesis of Rheumatoid Arthritis. Dr. Kristin Demoruelle
Mortality in Rheumatoid Arthritis: A Story of Decline, Delay, or Plateau? Dr. Elena Myasoedova
Mortality in Rheumatoid Arthritis: A Story of Decline, Delay, or Plateau? Dr. Elena Myasoedova
Poets Know It (3.13.2026)
Dr. Jack Cush reviews the news, regulatory decisions and new journal articles.
UBER Rheumatology Ride (3.6.2026)
Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com
Early Decisions and Impact: An IL-23 Inhibitor in Bio-Naive Patients With PsA
Sponsored by AbbVie Medical Affairs + Health Impact
DERM on RheumNow PODCAST (February 2026)
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.
Features Dr. Jack Cush, Editor at RheumNow.com.
SHOW NOTES
FDA sent a complete response letter to AstraZeneca on their application (BLA) for anifrolu
SATISFACTION (2.27.2026)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
Referral Rules to Live By (2.20.2026)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. Highlights include referral rules, combination biiologics in psoriasis and don't use JAK inhibitors in pregnancy.
Maui Potpourri (2.13.2026)
Dr.Jack Cush reviews the hot item takeaways from last weeks RheumNow.Live 2026
Diet & Obesity Management in Rheumatology - Uzma Haque, MD
Mitigating risk for Rheum patients undergoing orthopedic surgery - Susan Goodman, MD
Paradoxical skin reactions – Dr. Joseph Merola
Mortality in RA - Elena Myasoedova, MD
The Mucosal Hypothesis to RA - Kristin Demourelle, MD
Advances in ILD - Jeffrey Sparks
ANA Pollution (2.06.2026)
Dr. Jack Cush reviews the news, journal articles and regulatory news from this past week on RheumNow.com
DERM on RheumNow PODCAST (January 2026)
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.
Features Dr. Jack Cush, Editor at RheumNow.com.
SHOW NOTES
Lupus Accelerating Breakthroughs Consortium commissioned a stakeholders group (including t
RheumNow Live Preview (1.30.2026)
Dr. Jack Cush reviews the news and journal reports from RheumNow.com
Top 5 reasons to attend RheumNow Live 2026
1. Its cold and far, but you can be there virtually, online
2. Ffull access to handouts, slides & downloads
3. Saturday concert with Colin Boyd
4. Rohit Agarwal does TWO STEP talks!
5. Download 400+ rheumatology review Questions
REGISTER at - RheumNow.live
Focus on Guidelines
Join us for our next webinar: Focus on Guidelines. Panelists will discuss their approaches to a range of difficult cases in multiple areas, including rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis and vasculitis, and discuss how they apply the guidelines in everyday practice. You’ll hear different perspectives and practical tips you can use in clinic.
Panelists:
Audrey Gib
Emergencies, Independence & Hemorrhage (1.23.2026)
Dr. Jack Cush reviews the news and reports from the past two weeks on RheumNow.Com
2025 Rheumatology Year in Review (1.16.26)
Dr. Jack Cush reviews rheumatology's highlights, advances and noteworthy trends from the past year - 2025!
APP Podcast Series Part Two
1- Sex & the Rheum Patient (12:17)
2- Pain Management (17.58)
3- Lifestyle (15.38)
APP Podcast Series Part One
This podcast is part one of the Mission: APP Partners in Care Therapeutic Update Series called Underserved and under-treated. This podcast includes videos from: Daric Mueller, PA-C, Rachel Busch-Feuer, DNP, Betsy Kirchner, DNP, Lindsay Tom, PA-C and Vanessa Hill, NP-C
2026 Resolutions (1.9.2026)
Dr. Jack Cush reviews the news, announcements and journal articles from this past week on RheumNow.com. More on Variable bendability, a better way to treat RA, and a novel advance for GLP1a in PsA; and 2026 Resolutions!
DERM on RheumNow Podcast (December 2025)
Features Dr. Jack Cush
Recommended
The Young and Called Podcast .
Jubal Phone Pranks from The Jubal Show
پلی لیست | PlayList
English with Olivia | Slow Conversations & Vocabulary
Bible Tea
TED Talks Daily
Pod Save America
Dateline NBC
صداستان: ساعتی با موسیقی
Becoming: HER with Nikki Spoelstra
Exposing Workplace Bullying
Everyday AI Made Simple - AI For Everyday Tasks
